Coloplast A/S CLPBY OTC

Coloplast A/S (CLPBY) reported total assets of $48.46B and total liabilities of $32.31B for fiscal year 2025, resulting in total equity of $16.15B.

The company held $948.88M in cash and short-term investments. Total debt stood at $22.68B, with net debt of $21.74B. The Debt-to-Equity (D/E) ratio was 1.4 (moderate).

Current ratio is 1.61, indicating strong short-term liquidity. Interest coverage is 9.2x (strong).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 1.4, current ratio of 1.61, interest coverage 9.2x — balance sheet is strong
• MOAT (75/100) — Total assets $48.46B and equity $16.15B support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 1.4 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 72/100 with 4/7 criteria passed.

ESLOY

EssilorLuxottica SA

$120.76

+3.72%

ESLOF

EssilorLuxottica SA

$239.28

+4.06%

HOCPY

HOYA Corporation

$187.73

+0.59%

SAUHY

Straumann Holding AG

$11.16

+3.38%

SSMXY

Sysmex Corporation

$8.82

+0.68%

ANSLY

Ansell Limited

$83.53

+0.00%

CZMWY

Carl Zeiss Meditec AG

$31.85

+3.07%

CZMWF

Carl Zeiss Meditec AG

$31.83

+3.11%